FORTE BIOSCIENCES, INC. Net Income (Loss), Including Portion Attributable to Noncontrolling Interest
FORTE BIOSCIENCES, INC. (FBRX) reported Net Income (Loss), Including Portion Attributable to Noncontrolling Interest of -$45.47 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Income Statement › Net Income
us-gaap:ProfitLoss · last filed 2026-08-12
- FORTE BIOSCIENCES, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-06-30 was -$23.33M.
- FORTE BIOSCIENCES, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2026-03-31 was -$22.14M.
- FORTE BIOSCIENCES, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-12-31 was -$24.79M.
- FORTE BIOSCIENCES, INC. net income (loss), including portion attributable to noncontrolling interest for the quarter ending 2025-09-30 was -$17.68M.
- FORTE BIOSCIENCES, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2025 was -$69.38M.
- FORTE BIOSCIENCES, INC. net income (loss), including portion attributable to noncontrolling interest for fiscal 2024 was -$35.48M.
| Period end | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 3 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 6 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 9 month | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$23.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$45.47M 10-Q · filed 2026-08-12 | -$70.25M derived: sum of 3 quarters · filed 2026-08-12 | -$87.94M derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | -$22.14M 10-Q · filed 2026-05-11 | -$46.92M derived: sum of 2 quarters · filed 2026-05-11 | -$64.61M derived: sum of 3 quarters · filed 2026-05-11 | -$75.86M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-12-31 | -$24.79M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$42.47M derived: sum of 2 quarters · filed 2026-03-31 | -$53.72M derived: sum of 3 quarters · filed 2026-08-12 | -$69.38M 10-K · filed 2026-03-31 |
| 2025-09-30 | -$17.68M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$28.93M derived: sum of 2 quarters · filed 2026-08-12 | -$44.59M 10-Q · filed 2025-11-14 | -$51.74M derived: sum of 4 quarters · filed 2026-08-12 |
| 2025-06-30 | -$11.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | -$26.91M 10-Q · filed 2026-08-12 | -$34.06M derived: sum of 3 quarters · filed 2026-08-12 | |
| 2025-03-31 | -$15.66M 10-Q · filed 2026-05-11 | -$22.81M derived: sum of 2 quarters · filed 2026-05-11 | ||
| 2024-12-31 | -$7.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | -$35.48M 10-K · filed 2026-03-31 | ||
| 2024-09-30 | -$28.32M 10-Q · filed 2025-11-14 |